Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Cas9 activators in multiple species
Alejandro Chavez, Marcelle Tuttle, Benjamin W. Pruitt, et al.
Nature Methods (2016) Vol. 13, Iss. 7, pp. 563-567
Open Access | Times Cited: 502

Showing 1-25 of 502 citing articles:

The CRISPR tool kit for genome editing and beyond
Mazhar Adli
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 1460
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung, Silvana Konermann, Jonathan S. Gootenberg, et al.
Nature Protocols (2017) Vol. 12, Iss. 4, pp. 828-863
Open Access | Times Cited: 1107
Diversity and evolution of class 2 CRISPR–Cas systems
Sergey Shmakov, Aaron A. Smargon, David Scott, et al.
Nature Reviews Microbiology (2017) Vol. 15, Iss. 3, pp. 169-182
Open Access | Times Cited: 965
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
Kendall R Sanson, Ruth E. Hanna, Mudra Hegde, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 806
Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation
Max A. Horlbeck, Luke A. Gilbert, Jacqueline E. Villalta, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 805
An enhanced CRISPR repressor for targeted mammalian gene regulation
Nan Cher Yeo, Alejandro Chavez, Alissa Lance‐Byrne, et al.
Nature Methods (2018) Vol. 15, Iss. 8, pp. 611-616
Open Access | Times Cited: 455
Cornerstones of CRISPR–Cas in drug discovery and therapy
Christof Fellmann, Benjamin G. Gowen, Pei‐Chun Lin, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 2, pp. 89-100
Open Access | Times Cited: 427
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation
Hsin‐Kai Liao, Fumiyuki Hatanaka, Toshikazu Araoka, et al.
Cell (2017) Vol. 171, Iss. 7, pp. 1495-1507.e15
Open Access | Times Cited: 403
Multiplexed CRISPR technologies for gene editing and transcriptional regulation
Nicholas S. McCarty, Alicia E. Graham, Lucie Studená, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 401
Am I ready for CRISPR? A user's guide to genetic screens
John G. Doench
Nature Reviews Genetics (2017) Vol. 19, Iss. 2, pp. 67-80
Closed Access | Times Cited: 392
CRISPR technologies for precise epigenome editing
Muneaki Nakamura, Yuchen Gao, Antonia A. Dominguez, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 1, pp. 11-22
Closed Access | Times Cited: 353
Complex transcriptional modulation with orthogonal and inducible dCas9 regulators
Yuchen Gao, Xin Xiong, Spencer S. Wong, et al.
Nature Methods (2016) Vol. 13, Iss. 12, pp. 1043-1049
Open Access | Times Cited: 314
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Martin Kampmann
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 406-416
Open Access | Times Cited: 313
Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing
Xiaoshu Xu, Augustine Chemparathy, Leiping Zeng, et al.
Molecular Cell (2021) Vol. 81, Iss. 20, pp. 4333-4345.e4
Open Access | Times Cited: 286
A CRISPR–dCas Toolbox for Genetic Engineering and Synthetic Biology
Xiaoshu Xu, Lei S. Qi
Journal of Molecular Biology (2018) Vol. 431, Iss. 1, pp. 34-47
Open Access | Times Cited: 283
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance
Assaf C. Bester, Jonathan D. Lee, Alejandro Chavez, et al.
Cell (2018) Vol. 173, Iss. 3, pp. 649-664.e20
Open Access | Times Cited: 278
CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency
Navneet Matharu, Sawitree Rattanasopha, Serena Tamura, et al.
Science (2018) Vol. 363, Iss. 6424
Open Access | Times Cited: 276
CRISPR/Cas9 for cancer research and therapy
Tianzuo Zhan, Niklas Rindtorff, Johannes Betge, et al.
Seminars in Cancer Biology (2018) Vol. 55, pp. 106-119
Open Access | Times Cited: 275
The CRISPR-Cas toolbox and gene editing technologies
Guanwen Liu, Qiupeng Lin, Shuai Jin, et al.
Molecular Cell (2021) Vol. 82, Iss. 2, pp. 333-347
Open Access | Times Cited: 264
From profiles to function in epigenomics
Stefan H. Stricker, Anna Köferle, Stephan Beck
Nature Reviews Genetics (2016) Vol. 18, Iss. 1, pp. 51-66
Open Access | Times Cited: 263
In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice
Haibo Zhou, Junlai Liu, Changyang Zhou, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 3, pp. 440-446
Closed Access | Times Cited: 257
CRISPR/Cas9-Based Engineering of the Epigenome
Julián Pulecio, Nipun Verma, Eva Mejía-Ramírez, et al.
Cell stem cell (2017) Vol. 21, Iss. 4, pp. 431-447
Open Access | Times Cited: 253
A potent Cas9-derived gene activator for plant and mammalian cells
Zhenxiang Li, Dandan Zhang, Xiangyu Xiong, et al.
Nature Plants (2017) Vol. 3, Iss. 12, pp. 930-936
Open Access | Times Cited: 233
Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editing
Daan C. Swarts, Martin Jínek
Wiley Interdisciplinary Reviews - RNA (2018) Vol. 9, Iss. 5
Closed Access | Times Cited: 229
Page 1 - Next Page

Scroll to top